Underdosed and Overdosed Product
An underdosed or overdosed product contains less or more active substance than its label claims, a deviation that silently rescales every conclusion drawn from using it.
Underdosing and overdosing describe a mismatch between the quantity of active substance a container actually holds and the quantity its label claims. Regulated products are released against a content specification, commonly a window such as ninety to one hundred and ten percent of label claim, verified by a quantitative assay before the batch is allowed out. Where no such specification is enforced, the delivered amount is whatever the fill process produced, and deviation in either direction is not exceptional.
Several mechanisms produce it without anyone intending fraud. Gross powder weight is not peptide weight, because counterion, residual water and process salts occupy part of it, so a vial filled by mass to a nominal figure contains less peptide than stated. Degradation during shipment outside a cold chain reduces intact content while leaving the label unchanged. Vials are also routinely overfilled on purpose so that the full labelled amount can be withdrawn, which is legitimate practice in regulated manufacture and a frequent source of confusion when buyers weigh or measure the excess and conclude they received a bonus.
The consequence is that every number derived downstream inherits the error. Concentration after reconstitution, apparent potency, apparent tolerability and any dose-response impression are all scaled by an unknown factor. Two lots differing in content by a third will read as differing in efficacy, and a compound will look inert when the vial was mostly excipient.
The error worth naming is inferring content from purity. A certificate stating ninety-nine percent purity says the material present is largely one species; it says nothing about how much material is present. High purity and severe underfill coexist comfortably, and only an assay against a reference standard distinguishes them.